Advancing precision
medicine for
Parkinson’s disease
Core-Oli-T AB is developing next-generation
antibody-based solution for diagnostics,
brain-imaging and therapeutics
Supported by a Strong Innovation Ecosystem
Originated from research and innovation at Linnaeus University and supported by
leading organizations within Sweden’s life science and innovation ecosystem.
Our Vision
At Core-Oli-T, we believe earlier detection and precision-targeted therapies can transform the future of Parkinson’s disease care. By combining advanced antibody technologies with translational research, we aim to create new possibilities for diagnostics, brain imaging and future therapeutic applications.
Precision Diagnostics
Developing antibody-based assays to enable earlier and more accurate detection of Parkinson’s disease.
Brain Imaging
Creating PET imaging agents that visualize disease-related alpha-synuclein in the brain.
Therapeutics
Building the foundation for future antibody-based therapies targeting alpha-synuclein pathology.